Angelini

Belkins
Angelini is a privately-held, mid-sized international manufacturer and marketer of pharmaceutical and healthcare products in the pharmaceutical and mass-market sectors.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

PHARMACY MARKET

TREOSULFAN, A FIRST-IN-CLASS CONDITIONING AGENT, IS LICENSED IN CANADA BY MEDEXUS PHARMACEUTICALS AND MEDAC GMBH

Medexus Pharmaceuticals | July 13, 2021

news image

Medexus Pharmaceuticals Inc. announced today that it has entered into a licensing deal with medac GmbH to commercialize treosulfan, a bifunctional alkylating agent, in Canada. Treosulfan will be sold in Canada as Trecondyv and will be used in conjunction with fludarabine as part of a conditioning regime before allogeneic hematopoietic stem cell transplantation. Medexus will be in charge of selling and promoting the product, while Medac will manufacture and supply it. ...

Read More

PHARMA TECH

GANNEX RECEIVED U.S. FDA FAST TRACK DESIGNATION FOR ITS NASH DRUG CANDIDATE ASC42,AN FXR AGONIST

Gannex | December 14, 2020

news image

Gannex, an entirely claimed organization of Ascletis Pharma Inc. (HKEX:1672) and completely committed to the R&D and commercialization of new medications in the field of NASH, reported today that it got Fast Track assignment from the U.S. Food and Drug Administration (FDA) for its non-alcoholic steatohepatitis (NASH) drug applicant ASC42. The U.S. FDA's Fast Track advancement program is intended to encourage the turn of events and speed up the survey of medications that ha...

Read More

PHARMACY MARKET

PFIZER AND BIONTECH ANNOUNCE A PARTNERSHIP WITH BIOVAC TO DEVELOP AND DISTRIBUTE COVID-19 VACCINE DOSES IN AFRICA

Pfizer | July 22, 2021

news image

Pfizer Inc. and BioNTech SE today announced the signing of a letter of intent with The Biovac Institute (Pty) Ltd, also known as "Biovac," a South African biopharmaceutical business headquartered in Cape Town, to produce the Pfizer-BioNTech COVID-19 Vaccine for sale inside the African Union. Biovac will manufacture and distribute COVID-19 vaccines as part of Pfizer and BioNTech's worldwide COVID-19 vaccine supply chain and production network, which currently spans th...

Read More

PCI PHARMA SERVICES ANNOUNCES GLOBAL CLINICAL FOOTPRINT WITH CREATION COE IN WESTERN EUROPE

PCI Pharma Services | July 28, 2020

news image

PCI Pharma Services, a leading pharmaceutical and biopharmaceutical global outsourcing solutions provider, today announced a significant milestone in its global clinical footprint with the creation of a new Clinical Center of Excellence (COE) in Western Europe at its Berlin location, a major investment that will represent a new flagship site for customers. This is part of PCI’s global strategy to expand its clinical supply-chain network into continental Europe to complement offerings avail...

Read More

PHARMACY MARKET

Medexus Pharmaceuticals | July 13, 2021

news image

TREOSULFAN, A FIRST-IN-CLASS CONDITIONING AGENT, IS LICENSED IN CANADA BY MEDEXUS PHARMACEUTICALS AND MEDAC GMBH

Medexus Pharmaceuticals Inc. announced today that it has entered into a licensing deal with medac GmbH to commercialize treosulfan, a bifunctional alkylating agent, in Canada. Treosulfan will be sold in Canada as Trecondyv and will be used in conjunction with fludarabine as part of a conditioning regime before allogeneic hematopoietic stem cell transplantation. Medexus will be in charge of selling and promoting the product, while Medac will manufacture and supply it. ...

Read More

PHARMA TECH

Gannex | December 14, 2020

news image

GANNEX RECEIVED U.S. FDA FAST TRACK DESIGNATION FOR ITS NASH DRUG CANDIDATE ASC42,AN FXR AGONIST

Gannex, an entirely claimed organization of Ascletis Pharma Inc. (HKEX:1672) and completely committed to the R&D and commercialization of new medications in the field of NASH, reported today that it got Fast Track assignment from the U.S. Food and Drug Administration (FDA) for its non-alcoholic steatohepatitis (NASH) drug applicant ASC42. The U.S. FDA's Fast Track advancement program is intended to encourage the turn of events and speed up the survey of medications that ha...

Read More

PHARMACY MARKET

Pfizer | July 22, 2021

news image

PFIZER AND BIONTECH ANNOUNCE A PARTNERSHIP WITH BIOVAC TO DEVELOP AND DISTRIBUTE COVID-19 VACCINE DOSES IN AFRICA

Pfizer Inc. and BioNTech SE today announced the signing of a letter of intent with The Biovac Institute (Pty) Ltd, also known as "Biovac," a South African biopharmaceutical business headquartered in Cape Town, to produce the Pfizer-BioNTech COVID-19 Vaccine for sale inside the African Union. Biovac will manufacture and distribute COVID-19 vaccines as part of Pfizer and BioNTech's worldwide COVID-19 vaccine supply chain and production network, which currently spans th...

Read More

PCI Pharma Services | July 28, 2020

news image

PCI PHARMA SERVICES ANNOUNCES GLOBAL CLINICAL FOOTPRINT WITH CREATION COE IN WESTERN EUROPE

PCI Pharma Services, a leading pharmaceutical and biopharmaceutical global outsourcing solutions provider, today announced a significant milestone in its global clinical footprint with the creation of a new Clinical Center of Excellence (COE) in Western Europe at its Berlin location, a major investment that will represent a new flagship site for customers. This is part of PCI’s global strategy to expand its clinical supply-chain network into continental Europe to complement offerings avail...

Read More